Skip to main content
. 2026 Mar 13;18(3):355. doi: 10.3390/v18030355
AMR Antimicrobial Resistance
HRDR Host Range Determinant Region
ACR Anti-CRISPR
MRSA Methicillin-Resistant Staphylococcus aureus
PEG Polyethylene Glycol
MDR Multidrug-Resistant
XDR Extensively Drug-Resistant
EPEs Engineered Phage Enzymes
IBD Inflammatory Bowel Disease
CRC Colorectal Cancer
NAFLD Non-Alcoholic Fatty Liver Disease
NE Neutrophil Elastase
CRKP Carbapenem-Resistant Klebsiella pneumoniae
TME Tumor Microenvironment
UC Ulcerative Colitis
DIO Diet-Induced Obesity
BCa Breast Cancer
GMP Good Manufacturing Practice
eIND emergency Investigational New Drug
PK Pharmacokinetic
PD Pharmacodynamic
RCTs Randomized Controlled Trials